A trial in Nigeria found that providing lipid-based nutritional supplements increased measles vaccination coverage in children aged 6-23 months.

What it means

This is a trial in Nigeria (the NutriVax trial) testing whether giving toddlers aged 6–23 months a small-quantity lipid-based nutritional supplement on vaccination day improves measles vaccination coverage. The results show that children offered the supplement were substantially more likely to be vaccinated against measles — reported as roughly a 20.1 percentage-point increase in coverage after one year and about double the odds of measles vaccination. In plain terms, pairing a cheap nutritional supplement with routine immunization visits appears to get more children vaccinated.

Accuracy & sourcesGrounded

The claim rests on a peer-reviewed trial report in Nature Medicine (doi:10.1038/s41591-026-04675-1), so it is a primary-source result rather than a secondary summary. The search results corroborate the same trial through its published protocol and NGO coverage, though the specific effect sizes should be read as coming from this single Nigerian trial, not a broad meta-analysis.

How new